Jane Street’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Buy
+62,200
New +$1.4M ﹤0.01% 5975
2025
Q4
Sell
-21,100
Closed -$525K 12110
2025
Q3
$525K Sell
21,100
-16,100
-43% -$346K ﹤0.01% 7758
2025
Q2
$856K Buy
37,200
+3,900
+12% +$90.3K ﹤0.01% 5911
2025
Q1
$748K Buy
33,300
+12,900
+63% +$300K ﹤0.01% 6111
2024
Q4
$399K Sell
20,400
-21,900
-52% -$434K ﹤0.01% 7240
2024
Q3
$770K Sell
42,300
-12,300
-23% -$235K ﹤0.01% 6410
2024
Q2
$949K Sell
54,600
-19,600
-26% -$347K ﹤0.01% 5874
2024
Q1
$1.45M Buy
74,200
+45,900
+162% +$969K ﹤0.01% 4710
2023
Q4
$652K Buy
28,300
+16,500
+140% +$369K ﹤0.01% 6309
2023
Q3
$271K Buy
11,800
+1,500
+15% +$38.1K ﹤0.01% 7209
2023
Q2
$269K Sell
10,300
-3,400
-25% -$89.8K ﹤0.01% 7288
2023
Q1
$378K Sell
13,700
-82,100
-86% -$2.17M ﹤0.01% 6812
2022
Q4
$2.18M Sell
95,800
-3,400
-3% -$94.6K ﹤0.01% 3741
2022
Q3
$3.38M Buy
+99,200
New +$3.67M ﹤0.01% 3254

Other funds holding PRVA

Jane Street's PRVA Position: Q1 2026 in Review

Jane Street increased its Privia Health (PRVA) stake by 153% in Q1 2026, buying an estimated $931K and bringing the position to 68,227 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #5768.

Jane Street first reported a position in PRVA in Q3 2021 and has held it in 14 quarters since. The position peaked at $5.85M in Q1 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Jane Street held 68,227 shares of Privia Health worth $1.4M as of Q1 2026.
  • Jane Street bought 41,303 Privia Health shares in Q1 2026, an estimated $931K.
  • Privia Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5768 holding.
  • Jane Street first reported a position in Privia Health in Q3 2021 and has held it in 14 quarters since.
  • Jane Street's Privia Health position peaked at $5.85M in Q1 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.